Flat maternal glucose response curve and adverse pregnancy outcome

Group HSCR. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002.

Langer O, Rodriguez DA, Xenakis EMJ, McFarland MB, Berkus MD, Arredondo F. Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol. 1994;1701036-46; discussion 1046-7.

Kjos SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med. 1999;341. https://doi.org/10.1056/NEJM199912023412307.

Langer O, Damus K, Maiman M, Divon M, Levy J, Bauman W. A link between relative hypoglycemia-hypoinsulinemia during oral glucose tolerance tests and intrauterine growth retardation. Am J Obstet Gynecol. 1986;155:711–6. https://doi.org/10.1016/S0002-9378(86)80004-7.

Article  CAS  PubMed  Google Scholar 

Naeh A, Wilkof-Segev R, Jaffe A, Maor-Sagie E, Hallak M, Gabbay-Benziv R. Flat oral glucose tolerance test during pregnancy: maternal characteristics and risk for adverse outcomes. Clin Diab. 2021;39:313–319.

Valensise H, Romanini C. Second-trimester uterine artery flow velocity waveform and oral glucose tolerance test as a means of predicting intrauterine growth retardation. Ultrasound Obstet Gynecol. 1993;3:412–6.

Mccowen MKD.O’sarr TP. Clinical implications of the flat oral glucose tolerance test. Mil Med. 1979;144:177–9.

Pakhetra R, Garg MK, Saini JS. Is beta cell dysfunction responsible for flat glucose tolerance curve in primary hypothyroidism? Med J Armed Forces India. 2001;57:120–5.

Das Gupta DS, Whitehouse FW. Significance of the flat oral glucose tolerance test. Postgraduate Med. 2016;49:55–9.

Google Scholar 

Nolan S, Stephan T, Khurana KC, Morgan CR, Danowski TS. Low profile (flat) glucose tolerances. Am J Med Sci. 1972;264:33–9. https://doi.org/10.1097/00000441-197207000-00005.

Article  CAS  PubMed  Google Scholar 

Abell DA. The significance of abnormal glucose tolerance (hyperglycaemia and hypoglycaemia) in pregnancy. Br J Obsteirics. 1979;86:214–21.

Article  CAS  Google Scholar 

Carpenter MW, Coustan DR. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol. 1982;144:768–73. https://doi.org/10.1016/0002-9378(82)90349-0.

Article  CAS  PubMed  Google Scholar 

Nicolaides KH, Wright D, Syngelaki A, Wright A, Akolekar R. Fetal medicine foundation fetal and neonatal population weight charts. Ultrasound Obstet Gynecol. 2018;52:44–51. https://doi.org/10.1002/uog.19073.

Article  CAS  PubMed  Google Scholar 

Soothill PW, Nicolaides KH, Campbell S. Prenatal asphyxia, hyperlacticaemia, hypoglycaemia, and erythroblastosis in growth retarded fetuses. BMJ 1987;294:1051–3.

Thorn S, Rozance P, Brown L, Hay W. The intrauterine growth restriction phenotype: Fetal adaptations and potential implications for later life insulin resistance and diabetes. Sem Reprod Med. 2011;29:225–36

Brody S. Screening for gestational diabetes: a summary of the evidence for the U.S. preventive services task force. Obstet Gynecol. 2003;101:531–8.

Coustan DR, Carpenter MW. The diagnosis of gestational diabetes. Diab Care. 1998;21:B5–8.

Abell DA, Beischer NA. Evaluation of the three-hour oral glucose tolerance test in detection of dignificant hyperglycemia and hypoglycemia in pregnancy. Diabetes. 1975;24:874–80.

Abell DA, Beischer NA, Papas AJ, Willis MM. The association between abnormal glucose tolerance (hyperglycemia and hypoglycemia) and estriol excretion in pregnancy. Am J Obstet Gynecol. 1976;124:388–92.

Bayraktar B, Meriç B, Ahkam GK. Pregnancy outcomes of women with hypoglycemia in the oral glucose tolerance test. J Gynecol Obstet Human Reprod. 2020;49. https://doi.org/10.1016/j.jogoh.2020.101703.

Weissman A, Solt I, Zloczower M, Jakobi P. Hypoglycemia during the 100-g oral glucose tolerance test: incidence and perinatal significance. Obstet Gynecol. 2005;105:1424–8.

Sheiner E, Levy A, Katz M, Hershkovitz R, Leron E, Mazor M. Gender does matter in perinatal medicine. Fetal Diag Therapy. 2004;19:366–9.

Retnakaran R, Kramer CK, Ye C, Kew S, Hanley AJ, Connelly PW, et al. Fetal sex and maternal risk of gestational diabetes mellitus: the impact of having a boy. Diabet Care. 2015;38:844–51.

Krantz D, Goetzl L, Simpson JL, Thom E, Zachary J, Hallahan T. W, et al. Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol. 2004;191:1452–8.

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif